- Global Pharma News & Resources

Oxytocic Pharmaceuticals Market To Witness CAGR Tremendous 7.74% CAGR By 2031: Future Market Insights

Though synthetic oxytocin is chemically equivalent to naturally-occurring oxytocin, their pharmaceutical functions for aiding women in labour are quite distinctive. Medical professionals from around the world will continue to recommend synthetic-based oxytocic pharmaceuticals over natural since oxytocic pharmaceuticals originating from synthetic sources can boost the momentum of decelerated labour by IV administration.

More than 90% of the global market revenues for oxytocic pharmaceuticals will be harvested from the sales of oxytocic pharmaceuticals originating from synthetic sources. By the end of 2031, an estimated US$ 207.80 million revenues will be emanated from the global sales of synthetic oxytocic pharmaceuticals.

Future Market Insights’ published report on the global oxytocic pharmaceuticals market estimates that the market, which is presently valued at US$ 62.2 million, will expand at an impressive 7.74% CAGR to reach US$ 207.80 million value by 2031-end. In the report, titled “Oxytocic Pharmaceuticals Market: Global Industry Analysis & Opportunity Assessment, 2021-2031,”

Request For Report Sample @

Future Market Insights projects that the global market for oxytocic pharmaceuticals will remain highly fragmented due to higher prevalence of local players as opposed to multinationals and conglomerates. Nevertheless, global pharmaceutical industry leaders such as Pfizer Inc., Novartis AG, Baxter Healthcare Corporation, and Teva Pharmaceutical Industries Ltd. are also partaking in the global oxytocic pharmaceuticals market. Other leading manufacturers of oxytocic pharmaceuticals include Biofutura Pharma SpA, Ferring BV, and Fresenius Kabi AG.

Global Oxytocic Pharmaceuticals Market: Regional Analysis

The need for oxytocic pharmaceuticals in the world will always remain contingent to the rise in pregnancy incidences and birth rate. Various parts of the world exhibit diverse birth rate, which incidentally drives the growth of their oxytocic pharmaceuticals market, accordingly. In North America, oxytocic pharmaceuticals are majorly used for postpartum haemorrhage, which is one of the most-prominent indication among labouring women in the US and Canada.

However, China is expected to remain the largest market for oxytocic pharmaceuticals in the world. Considering the country’s exploding birth rate, China’s oxytocic pharmaceuticals market will be valued over US$ 55 million by 2031-end, expanding at 9.8% CAGR. In 2016, Japan’s oxytocic pharmaceuticals revenues amounted to an estimated US$ 1.7 million, while the oxytocic pharmaceuticals market in Asia-Pacific excluding Japan & China (APEJC) region has been estimated to account for nearly 20% of global revenues.

Queries about Report, Ask an Expert @

Global Oxytocic Pharmaceuticals Market: Research Highlights

  • Licensing agreements for development of newer oxytocic pharmaceuticals is rampantly boosting the global market revenues, profiting local players as well as industry leaders.
  • Surging prevalence of labour induction procedures for child births will continue promoting the use of oxytocic pharmaceuticals throughout the forecast period.
  • The global oxytocic pharmaceuticals revenues, however, are projected to witness an inhibited growth on the account of rising preference to alternative drugs such as magnesium sulphate and misoprostol.
  • India’s contribution to the APEJC oxytocic pharmaceuticals market is predicted to reach nearly 60% by the end of 2031.
  • More than 22,000 thousand units of oxytocic pharmaceuticals will be sold globally for treating labour arrest over the forecast period.
  • Hospitals will remain the largest end-user of oxytocic pharmaceuticals in the world, revenues from which will expand beyond 12% CAGR.
  • A majority of medical professionals in the world will recommend intravenous administration of oxytocic pharmaceuticals, accounting for more than two-third of global market revenues by the end of 2031.

Request For Report TOC @

Key Questions Answered in the Report

  • How much is the Oxytocic Pharmaceuticals Market Worth?

The global oxytocic pharmaceuticals market will reach a valuation of US$ 98.60 Mn in 2021, rising at a CAGR of 7.74% between 2021 and 2031.

  • At What Rate did the Oxytocic Pharmaceuticals Market Grow in the Last Five Years?

The oxytocic pharmaceuticals market exhibited growth at 3.60% CAGR between 2016 and 2020.

  • What is the Market Share of Top Players in Oxytocic Pharmaceuticals Market?

The combined market share of tier-1 players stood at 35-40% of the overall market.

  • What is the North America Oxytocic Pharmaceuticals Outlook?

The demand for oxytocic pharmaceuticals is expected to grow at 9% in North America between 2021 and 2031.

  • At What Percentage will Germany drive sales of Oxytocic Pharmaceuticals in European region?

In 2021, Germany will account for approximately 31% share of oxytocic pharmaceuticals in the European region.

  • Which are top 5 Countries driving Oxytocic Pharmaceuticals demand?

China, India, U.S., Japan, and GCC Countries are driving demand for oxytocic

  • What is driving demand for Oxytocic Pharmaceuticals Market?

Increasing labour induction procedures, growing prevalence of PPH and prequalification from WHO will drive the sales of Oxytocic Pharmaceuticals.

Buy Industry Research Report @

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.


Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates


For Sales Enquiries:

For Media Enquiries:

Editor Details

Last Updated: 04-Nov-2021